Physician profile
Nathan Abdelsayed
NPI 1295230142
$9,268.93
in general payments reported to CMS, 2019-2025
14 companies · $992 in 2025
The $992 reported for 2025 was more than what a typical Pain Medicine provider received nationally (typical 2025 total: $515).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,229 · 2022: $102 · 2023: $4,944 · 2024: $2,002 · 2025: $992.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,641 · Food and Beverage: $3,297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,641.16 |
| Food and Beverage | $3,296.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,533.69 | 2023-2025 | Proclaim, Eterna, Octrode |
| Medtronic, INC. | $1,207.58 | 2022-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Inceptiv |
| Legacy Ortho LLC | $1,200.00 | 2021 | |
| Boston Scientific Corporation | $459.41 | 2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Spr Therapeutics, INC | $259.59 | 2024-2025 | Sprint Pns System |
| Painteq LLC | $173.12 | 2023 | Painteq |
| Abbvie INC. | $160.25 | 2022-2025 | |
| Lilly USA, LLC | $58.68 | 2025 | Mounjaro, Zepbound |
| Stryker Corporation | $58.16 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Glaxosmithkline, LLC. | $44.20 | 2024-2025 | Arexvy, Shingrix |
| Pacira Pharmaceuticals Incorporated | $40.39 | 2023 | Iovera |
| Allergan, INC. | $29.18 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $26.03 | 2025 | |
| Tandem Diabetes Care, INC. | $18.65 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Abdelsayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.